Seroatlas · Human Serome Atlas

SLC7A7

Y+L amino acid transporter 1

Also known as: LPI, y+LAT-1, YLAT1_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q9UM01
Gene
SLC7A7
Ensembl
ENSG00000155465
Chromosome
14
Canonical length
511 aa
Protein class
Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters

OverviewNCBI Gene

The protein encoded by this gene is the light subunit of a cationic amino acid transporter. This sodium-independent transporter is formed when the light subunit encoded by this gene dimerizes with the heavy subunit transporter protein SLC3A2. This transporter is found in epithelial cell membranes where it transfers cationic and large neutral amino acids from the cell to the extracellular space. Defects in this gene are a cause of lysinuric protein intolerance (LPI). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2011]

Canonical amino-acid sequenceUniProt

511 residues, UniProt reviewed canonical sequence.

>Q9UM01|SLC7A7
     1  MVDSTEYEVA SQPEVETSPL GDGASPGPEQ VKLKKEISLL NGVCLIVGNM IGSGIFVSPK
    61  GVLIYSASFG LSLVIWAVGG LFSVFGALCY AELGTTIKKS GASYAYILEA FGGFLAFIRL
   121  WTSLLIIEPT SQAIIAITFA NYMVQPLFPS CFAPYAASRL LAAACICLLT FINCAYVKWG
   181  TLVQDIFTYA KVLALIAVIV AGIVRLGQGA STHFENSFEG SSFAVGDIAL ALYSALFSYS
   241  GWDTLNYVTE EIKNPERNLP LSIGISMPIV TIIYILTNVA YYTVLDMRDI LASDAVAVTF
   301  ADQIFGIFNW IIPLSVALSC FGGLNASIVA ASRLFFVGSR EGHLPDAICM IHVERFTPVP
   361  SLLFNGIMAL IYLCVEDIFQ LINYYSFSYW FFVGLSIVGQ LYLRWKEPDR PRPLKLSVFF
   421  PIVFCLCTIF LVAVPLYSDT INSLIGIAIA LSGLPFYFLI IRVPEHKRPL YLRRIVGSAT
   481  RYLQVLCMSV AAEMDLEDGG EMPKQRDPKS N

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against SLC7A7 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
12
Mean surface accessibility (rSASA)
0.26
Highest tissue expression
253 nTPM

Expression across tissuesHPA

Tissue

  • kidney: 253 nTPM
  • small intestine: 114 nTPM
  • duodenum: 92 nTPM
  • parathyroid gland: 71 nTPM
  • spleen: 66 nTPM
  • lung: 49 nTPM

Single-cell type

  • kupffer cells: 638 nCPM
  • enterocytes: 428 nCPM
  • hofbauer cells: 220 nCPM
  • monocytes: 199 nCPM
  • proximal tubule cells: 178 nCPM
  • early spermatids: 134 nCPM

Immune cell

  • non-classical monocyte: 447 nTPM
  • intermediate monocyte: 394 nTPM
  • classical monocyte: 289 nTPM
  • total PBMC: 148 nTPM
  • myeloid DC: 94 nTPM
  • neutrophil: 37 nTPM

Brain region

  • white matter: 14 nTPM
  • thalamus: 12 nTPM
  • medulla oblongata: 11 nTPM
  • pons: 10 nTPM
  • spinal cord: 8 nTPM
  • choroid plexus: 6.3 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about SLC7A7.

Disease | AllUniProt

Conditions SLC7A7 is implicated in, by any mechanism.

Disease | GeneticClinVar

158 pathogenic / likely-pathogenic of 903 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.96
gnomAD pLI
0
gnomAD missense Z
0.48
DepMap mean gene effect
0.03
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of SLC7A7 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads SLC7A7 as an antibody target. Whether an autoantibody or antibody against SLC7A7 could matter depends on whether native SLC7A7 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

SLC7A7 is annotated at the cell surface, where native SLC7A7 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label SLC7A7 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/SLC7A7. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...